Authors:
Szatmari, I
Biyashev, D
Tomboly, C
Toth, G
Macsai, M
Szabo, G
Borsodi, A
Lengyel, I
Citation: I. Szatmari et al., Influence of degradation on binding properties and biological activity of endomorphin 1, BIOC BIOP R, 284(3), 2001, pp. 771-776
Authors:
Zhao, JQ
Glasspool, RM
Hoare, SF
Bilsland, A
Szatmari, I
Keith, WN
Citation: Jq. Zhao et al., Activation of telomerase RNA gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3, NEOPLASIA, 2(6), 2000, pp. 531-539
Authors:
Jemnitz, K
Levai, F
Monostory, K
Szatmari, I
Vereczkey, L
Citation: K. Jemnitz et al., The in vitro biosynthesis and stability measurement with agyl-glycuronide isoformes of the main metabolite of ipriflavone, EUR J DRUG, 25(3-4), 2000, pp. 153-160
Citation: Z. Szondy et I. Szatmari, Apoptosis of CD4+T cells in Sjogren's syndrome: comment on the article by Zeher et al - Reply, ARTH RHEUM, 43(5), 2000, pp. 1188-1188
Authors:
Szatmari, I
Tokes, S
Dunn, CB
Bardos, TJ
Aradi, J
Citation: I. Szatmari et al., Modified telomeric repeat amplification protocol: A quantitative radioactive assay for telomerase without using electrophoresis, ANALYT BIOC, 282(1), 2000, pp. 80-88
Authors:
Szatmari, I
Toth, G
Kertesz, I
Schiller, PW
Borsodi, A
Citation: I. Szatmari et al., Synthesis and binding characteristics of [H-3] H-Tyr-Tic psi[CH2-NH] Cha-Phe-OH, a highly specific and stable delta-opioid antagonist, PEPTIDES, 20(9), 1999, pp. 1079-1083
Authors:
Sartania, N
Szatmari, I
Orosz, G
Ronai, AZ
Medzihradszky, K
Borsodi, A
Benyhe, S
Citation: N. Sartania et al., Irreversible labelling of the opioid receptors by a melphalan-substituted [Met(5)]enkephalin-Arg-Phe derivative, EUR J PHARM, 373(2-3), 1999, pp. 241-249
Authors:
Szatmari, I
Orosz, G
Medzihradszky, K
Borsodi, A
Citation: I. Szatmari et al., Affinity labeling of delta opioid receptors by an enkephalin-derivative alkylating agent, DSLET-Mal, BIOC BIOP R, 265(2), 1999, pp. 513-519